From: From animal models to human disease: a genetic approach for personalized medicine in ALS
Mutation | Age at onset (years ± SD) | Site at onset | Survival (months ± SD) | Clinical manifestations | References | |||
---|---|---|---|---|---|---|---|---|
UMN | LMN | Cognitive symptoms | Neuropathological findings | |||||
G287S | 62.3 ± 9.3 | Bulbar, Spinal | 76 ± 15.4 | Y | Y | N |  | |
G290A | 49.5 ± 2.1 | Bulbar, Spinal | 12a | Y | Y | N |  | [123] |
G298S | 50.7 ± 6.2 | Bulbar, Spinal | 27.0 ± 11.1 | Y | Y | N | Bunina bodies, gliosis, neuronal loss anterior horn, NCI, GCI | |
A315T | 65.5 ± 13.6 | Spinal | 109.7 ± 32.3 | Y | Y | N | Gliosis, spinal neuronal loss, NCI, neurofibrillary tangles, Aβ deposit | |
Q331Kb | 72 | Spinal | 36 | nd | nd | nd | Â | [122] |
M337V | 47.7 ± 8.8 | Bulbar, Spinal | 105.0 ± 59.6 | Y | Y | N | NCI, GCI, Bunina bodies | |
G348C | 46.4 ± 10.7 | Spinal | 81.3 ± 37 | Y | Y | Apathy, anxiety |  | |
A382T | 51.3 ± 8.6 | Bulbar, Spinal | 58.1 ± 44.4 | Y | Y | Dementia |  | |
N390Dc | 53 | Spinal | 35 | Y | Y | N | Â | [121] |